As an alternative strategy to control Tregs in vivo, we also used P60, a synthetic peptide that binds to FOXP3, a factor required for Treg development and function, thus inhibiting their function to protect against autoimmune diseases and prevent rejection of allogeneic transplants. Here, FOXP3 is linked to autoimmune disease.